180 related articles for article (PubMed ID: 32404956)
21. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.
Kim HJ; Seo JW; Roh MS; Lee JH; Song KH
J Am Acad Dermatol; 2018 Oct; 79(4):706-713. PubMed ID: 29673774
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of acral lentiginous histologic type in T1 melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Feldmeyer L; Namikawa K; Nagarajan P; Tetzlaff MT; Curry JL; Ross MI; Hwu WJ; Prieto VG; Aung PP
Mod Pathol; 2021 Mar; 34(3):572-583. PubMed ID: 32759976
[TBL] [Abstract][Full Text] [Related]
24. Acral lentiginous melanoma (including in situ melanoma) arising in association with naevocellular naevi.
Wong TY; Ohara K; Kawashima M; Sober AJ; Nogita T; Mihm MC
Melanoma Res; 1996 Jun; 6(3):241-6. PubMed ID: 8819127
[TBL] [Abstract][Full Text] [Related]
25. TERT and TERT promoter in melanocytic neoplasms: Current concepts in pathogenesis, diagnosis, and prognosis.
Motaparthi K; Kim J; Andea AA; Missall TA; Novoa RA; Vidal CI; Fung MA; Emanuel PO
J Cutan Pathol; 2020 Aug; 47(8):710-719. PubMed ID: 32202662
[TBL] [Abstract][Full Text] [Related]
26. Increased levels of β-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2.
Xu S; Yang Z; Zhang J; Jiang Y; Chen Y; Li H; Liu X; Xu D; Chen Y; Yang Y; Zhang Y; Li D; Xia J
DNA Cell Biol; 2015 Jan; 34(1):69-77. PubMed ID: 25343173
[TBL] [Abstract][Full Text] [Related]
27. Acral lentiginous melanoma: an immunohistochemical study of 20 cases.
Kim YC; Lee MG; Choe SW; Lee MC; Chung HG; Cho SH
Int J Dermatol; 2003 Feb; 42(2):123-9. PubMed ID: 12709000
[TBL] [Abstract][Full Text] [Related]
28. Expression of OPN3 in acral lentiginous melanoma and its associated with clinicohistopathologic features and prognosis.
Zeng W; Zhang W; Feng J; He X; Lu H
Immun Inflamm Dis; 2021 Sep; 9(3):840-850. PubMed ID: 33955704
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Melanocyte-Associated Immunohistochemical Markers in Acral Lentiginous Melanoma and Acral Benign Nevi.
Kim JC; Choi JW; Kim YC
Am J Dermatopathol; 2023 Nov; 45(11):748-752. PubMed ID: 37856738
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and Management of Acral Lentiginous Melanoma.
Nakamura Y; Fujisawa Y
Curr Treat Options Oncol; 2018 Jun; 19(8):42. PubMed ID: 29951919
[TBL] [Abstract][Full Text] [Related]
31. Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians.
Carrera C; Gual A; Díaz A; Puig-Butillé JA; Noguès S; Vilalta A; Conill C; Rull R; Vilana R; Arguis P; Vidal-Sicart S; Alós L; Palou J; Castel T; Malvehy J; Puig S
Melanoma Res; 2017 Aug; 27(4):315-320. PubMed ID: 28296711
[TBL] [Abstract][Full Text] [Related]
32. MAP Kinase Pathways: Molecular Roads to Primary Acral Lentiginous Melanoma.
Fernandes JD; Hsieh R; de Freitas LA; Brandao MA; Lourenço SV; Sangueza M; Nico MM
Am J Dermatopathol; 2015 Dec; 37(12):892-7. PubMed ID: 26588333
[TBL] [Abstract][Full Text] [Related]
33. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
34. TERT gene amplification is associated with poor outcome in acral lentiginous melanoma.
Diaz A; Puig-Butillé JA; Muñoz C; Costa D; Díez A; Garcia-Herrera A; Carrera C; Badenas C; Solé F; Malvehy J; Puig S; Alos L
J Am Acad Dermatol; 2014 Oct; 71(4):839-41. PubMed ID: 25219713
[No Abstract] [Full Text] [Related]
35. Acral Lentiginous Melanoma.
Goydos JS; Shoen SL
Cancer Treat Res; 2016; 167():321-9. PubMed ID: 26601870
[TBL] [Abstract][Full Text] [Related]
36. National Comprehensive Analysis of Characteristics of Acral Lentiginous Melanoma.
Huayllani MT; Restrepo DJ; Boczar D; Avila FR; Bagaria SP; Spaulding AC; Rinker BD; Forte AJ
Anticancer Res; 2020 Jun; 40(6):3411-3415. PubMed ID: 32487638
[TBL] [Abstract][Full Text] [Related]
37. Acral Spitz Nevi: A Clinicopathologic Study of 50 Cases With Immunohistochemical Analysis of P16 and P21 Expression.
Wiedemeyer K; Guadagno A; Davey J; Brenn T
Am J Surg Pathol; 2018 Jun; 42(6):821-827. PubMed ID: 29537991
[TBL] [Abstract][Full Text] [Related]
38. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S
Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426
[TBL] [Abstract][Full Text] [Related]
39. Acral lentiginous melanoma. A histological type without prognostic significance.
Cascinelli N; Zurrida S; Galimberti V; Bartoli C; Bufalino R; Del Prato I; Mascheroni L; Testori A; Clemente C
J Dermatol Surg Oncol; 1994 Dec; 20(12):817-22. PubMed ID: 7798414
[TBL] [Abstract][Full Text] [Related]
40. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type.
Torres-Cabala CA; Wang WL; Trent J; Yang D; Chen S; Galbincea J; Kim KB; Woodman S; Davies M; Plaza JA; Nash JW; Prieto VG; Lazar AJ; Ivan D
Mod Pathol; 2009 Nov; 22(11):1446-56. PubMed ID: 19718013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]